|
The Immunohistochemistry Antibody Company
|
|
|
General Cancer Screen 30 Tissue Microarray - LS-SCA30This tissue microarray is available for use in LSBio Immunohistochemistry Studies only. |
| Catalog ID: | LS-SCA30 |
| Product Name: | General Cancer Screen 30 |
| Description: | Various organ tumors and adjacent normal/non-neoplastic specimens |
| Format: | FFPE |
| Category: | Human Tumor and Adjacent Normal |
| QA/QC: | H&E reviewed |
| Storage: | Short term RT; Long term 4ºC |
| Clinical History: | No |
| Tissue Marker: | No |
| Stage/Grade: | Yes |
| Core Diameter: | 1.5 mm |
| Core Thickness: | 5 µm |
| Cases: | 44 |
| Cores: | 48 |
| Slides Per Set: | 1 |
LS-SCA30 Tissue Microarray Map
Slide Number 1
| LABEL |
|
Diagnosis Type Legend
| Benign non-neoplastic | Diseased | Inflammatory | Malignant | Metastatic | Tumor | Unknown |
Element Tissue Legend
Brain, Cerebrum (Brn); Breast (Bst); Breast, Fibrofatty tissue (Bst); Greater omentum (Gro); Greater omentum, Mesothelium (Gro); Kidney (Kid); Liver (Liv); Lung (Lng); Prostate (Pst); Small intestine (SmI); Small intestine, Duodenal ampulla (SmI);
LS-SCA30 Element Details
| Slide | Position | Species | Gender | Age | Tissue | Diagnosis | Diagnosis Type | Tumor Grade | Gleason Score |
|---|---|---|---|---|---|---|---|---|---|
| 1 | A1 | Human | F | 43 y | Liver (Liv) | Hepatocellular carcinoma | Malignant | 3 | |
| 1 | A2 | Human | F | 57 y | Lung (Lng) | Bronchioloalveolar carcinoma | Malignant | ||
| 1 | A3 | Human | F | 22 y | Brain, Cerebrum (Brn) | Glioblastoma | Malignant | 4 | |
| 1 | A4 | Human | F | 47 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | 2 | |
| 1 | A5 | Human | M | 64 y | Prostate (Pst) | Adenocarcinoma | Malignant | 2 | 2+4 |
| 1 | A6 | Human | F | 45 y | Small intestine, Duodenal ampulla (SmI) | Adenocarcinoma | Malignant | 1 | |
| 1 | A7 | Human | F | 54 y | Kidney (Kid) | Diffuse small B-cell lymphoma | Malignant | ||
| 1 | A8 | Human | F | 35 y | Greater omentum (Gro) | Metastatic adenocarcinoma | Metastatic | 3 | |
| 1 | B1 | Human | M | 48 y | Liver (Liv) | Hepatocellular carcinoma with necrosis | Malignant | 3 | |
| 1 | B2 | Human | M | 63 y | Lung (Lng) | Squamous cell carcinoma | Malignant | 2 | |
| 1 | B3 | Human | F | 43 y | Brain, Cerebrum (Brn) | Metastasis from breast infiltrating ductal carcinoma | Metastatic | 2 | |
| 1 | B4 | Human | F | 39 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | 2 | |
| 1 | B5 | Human | M | 69 y | Prostate (Pst) | Adenocarcinoma | Malignant | 1-2 | 2+3 |
| 1 | B6 | Human | F | 65 y | Small intestine (SmI) | Adenocarcinoma | Malignant | 2 | |
| 1 | B7 | Human | F | 14 y | Kidney (Kid) | Wilms' tumor (Nephroblastoma) | Tumor | ||
| 1 | B8 | Human | F | 57 y | Greater omentum (Gro) | Metastatic adenocarcinoma | Metastatic | 3 | |
| 1 | C1 | Human | M | 49 y | Liver (Liv) | Hepatocellular carcinoma | Malignant | 2 | |
| 1 | C2 | Human | M | 51 y | Lung (Lng) | Squamous cell carcinoma with necrosis | Malignant | ||
| 1 | C3 | Human | F | 47 y | Brain, Cerebrum (Brn) | Meningioma | Tumor | ||
| 1 | C4 | Human | F | 47 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | 2 | |
| 1 | C5 | Human | M | 77 y | Prostate (Pst) | Adenocarcinoma with basal cell hyperplasia | Malignant | ||
| 1 | C6 | Human | F | 70 y | Small intestine (SmI) | Adenocarcinoma | Malignant | 3 | |
| 1 | C7 | Human | F | 62 y | Kidney (Kid) | Clear cell carcinoma | Malignant | 1 | |
| 1 | C8 | Human | M | 61 y | Greater omentum (Gro) | Metastatic adenocarcinoma | Metastatic | ||
| 1 | D1 | Human | M | 48 y | Liver (Liv) | Adjacent normal with nodular cirrhosis | Diseased | ||
| 1 | D2 | Human | F | 57 y | Lung (Lng) | Adjacent normal | Benign non-neoplastic | ||
| 1 | D3 | Human | M | 52 y | Brain, Cerebrum (Brn) | Adjacent normal | Benign non-neoplastic | ||
| 1 | D4 | Human | F | 47 y | Breast, Fibrofatty tissue (Bst) | Adjacent normal | Benign non-neoplastic | ||
| 1 | D5 | Human | M | 74 y | Prostate (Pst) | Adjacent normal | Benign non-neoplastic | ||
| 1 | D6 | Human | F | 45 y | Small intestine (SmI) | Adjacent normal | Benign non-neoplastic | ||
| 1 | D7 | Human | F | 54 y | Kidney (Kid) | Adjacent normal | Benign non-neoplastic | ||
| 1 | D8 | Human | M | 75 y | Greater omentum (Gro) | Adjacent normal | Benign non-neoplastic | ||
| 1 | E1 | Human | M | 41 y | Liver (Liv) | Adjacent normal | Benign non-neoplastic | ||
| 1 | E2 | Human | M | 56 y | Lung (Lng) | Adjacent normal | Benign non-neoplastic | ||
| 1 | E3 | Human | M | 39 y | Brain, Cerebrum (Brn) | Adjacent normal | Benign non-neoplastic | ||
| 1 | E4 | Human | F | 53 y | Breast (Bst) | Adjacent normal | Benign non-neoplastic | ||
| 1 | E5 | Human | M | 27 y | Prostate (Pst) | Adjacent normal | Benign non-neoplastic | ||
| 1 | E6 | Human | F | 61 y | Small intestine (SmI) | Adjacent normal | Benign non-neoplastic | ||
| 1 | E7 | Human | F | 45 y | Kidney (Kid) | Adjacent normal | Benign non-neoplastic | ||
| 1 | E8 | Human | F | 21 y | Greater omentum, Mesothelium (Gro) | Normal | Benign non-neoplastic | ||
| 1 | F1 | Human | M | 40 y | Liver (Liv) | Adjacent normal | Benign non-neoplastic | ||
| 1 | F2 | Human | M | 52 y | Lung (Lng) | Adjacent normal | Benign non-neoplastic | ||
| 1 | F3 | Human | F | 33 y | Brain, Cerebrum (Brn) | Adjacent normal | Benign non-neoplastic | ||
| 1 | F4 | Human | F | 40 y | Breast (Bst) | Adjacent normal | Benign non-neoplastic | ||
| 1 | F5 | Human | M | 73 y | Prostate (Pst) | Adjacent normal | Benign non-neoplastic | ||
| 1 | F6 | Human | F | 54 y | Small intestine (SmI) | Adjacent normal | Benign non-neoplastic | ||
| 1 | F7 | Human | F | 49 y | Kidney (Kid) | Adjacent normal | Benign non-neoplastic | ||
| 1 | F8 | Human | F | 21 y | Greater omentum, Mesothelium (Gro) | Normal | Benign non-neoplastic |